Metastatic Dormancy and Progression in Thyroid Cancer: Targeting Cells in the Metastatic Frontier
- 1 May 2011
- journal article
- review article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 21 (5), 487-492
- https://doi.org/10.1089/thy.2011.2121
Abstract
Background: Metastatic dormancy, or the ability of cancer cells to survive but not progress in metastatic environments, is now recognized to be a common occurrence in cancer. Summary: From a clinical perspective, this phenomenon is common in metastatic well-differentiated thyroid cancer, whereby patients often present with distant metastases that remain stable for years after removal of the primary tumor and subsequent treatment. Experimental data suggest that metastases can develop throughout the life of a cancer and that progression in the distant environment depends on the biology of the cancer cells that metastasize as well as that of the various microenvironments they encounter. A firm understanding of how thyroid cancer cell progression is regulated in different metastatic environments is necessary to devise effective therapies targeting progressive metastatic thyroid cancer. Conclusion: In this review, current models of metastatic progression and factors that regulate late-stage metastatic progression that are particularly relevant for thyroid cancer are discussed.Keywords
This publication has 67 references indexed in Scilit:
- Extracellular matrix: A gatekeeper in the transition from dormancy to metastatic growthEuropean Journal of Cancer, 2010
- Extracellular Matrix Stiffness and Architecture Govern Intracellular Rheology in CancerBiophysical Journal, 2009
- Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1Nature, 2009
- Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkersNature, 2008
- Dysregulation of the Phosphatidylinositol 3-Kinase Pathway in Thyroid NeoplasiaEndocrinology and Metabolism Clinics of North America, 2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Metastasis Suppressors and the Tumor MicroenvironmentCancer Microenvironment, 2008
- Hypoxia-Inducible Factors, Stem Cells, and CancerCell, 2007
- MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancerNature, 2004
- THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST.The Lancet, 1889